COMP <GO>
RVTY vs LLY // ALTMAN Z-SCORE & DEBT/EQUITY
Revvity Inc. (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: RVTY 3
— LLY 12
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: LLY
LAST: $157.00 (-5.30%) • MKT CAP: $18.50B
balance-sheet
3.37
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
balance-sheet
9.29
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RVTY VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RVTY | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 83.64% | -42.64 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.10% | 32.36% | -29.26 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 48.2x | 36.4x | +11.78 | LLY | /valuation <GO> |
| Free Cash Flow Yield | 2.75% | 2.30% | +0.45 | RVTY | /fcf-yield <GO> |
| Operating Margin | 12.50% | 40.21% | -27.71 | LLY | /operating-margins <GO> |
| Net Profit Margin | 8.40% | 31.90% | -23.50 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 45.51% | -41.81 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.18% | 0.49% | -0.31 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.37 | 9.29 | -5.92 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.77% | -0.07 | RVTY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.1 | 77.9 | -22.78 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.51 | +0.44 | RVTY | /macro-sensitivity <GO> |
| Forward P/E Multiple | 71.3x | 26.3x | +45.05 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.50B | $1.33T | -$1.32T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RVTY REV | LLY REV | RVTY GROSS % | LLY GROSS % | RVTY FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.86B | $65.18B | 44.0% | 83.0% | $509.4M | $16.81B |
| FY 2024 | $2.76B | $45.04B | 44.0% | 81.3% | $541.7M | $8.82B |
| FY 2023 | $2.75B | $34.12B | 44.0% | 79.3% | -$32.5M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RVTY // BETA 0.95
LLY // BETA 0.51